Salesforce Q2 Earnings Beat on Investment Gains, Revenue View Raised

Salesforce reported Q2 fiscal 2027 non-GAAP EPS of $5.90, up 102.7% YoY and beating the Zacks Consensus by 80.43%. Revenue rose 10.8% YoY to $11.35B (slightly above consensus by 0.25%), with Agentic AI momentum (Agentforce ARR >$1.5B, +240% YoY) supporting strong cash flow (FCF +81.5% YoY to $1.10B). CRM raised fiscal 2027 revenue guidance to $46.10–$46.40B (+$200M) and increased non-GAAP EPS outlook to $16.67–$16.71, while continuing aggressive capital returns (dividends $364M and $25B accelerated buyback program; share count down 15% YoY).

Analysis

CRM is telling the market that enterprise software can still re-accelerate when AI is bundled into a control point rather than sold as a standalone add-on. The important mechanism is not the headline AI usage count; it is whether that usage converts into higher cRPO and tougher renewal pricing over the next 1-3 quarters. If that conversion holds, CRM can defend a premium multiple versus the broader software complex because it is monetizing workflow, data, and distribution together.

The quality of the beat is less clean than the optics suggest. A large chunk of the EPS upside was non-operating, so the market should be careful about extrapolating margin expansion from a quarter where core operating leverage was only modest. That creates a classic post-earnings risk: the stock can pop on the headline, but fade if investors focus on the sustainability of earnings power rather than the accounting lift.

Second-order winners are platform/software names that can sell AI into existing enterprise relationships, especially MSFT and NOW, while the losers are smaller point solutions that depend on being the 'AI layer' without owning the customer workflow. On the data side, higher ingestion and zero-copy activity is a read-through for cloud/storage demand, but only if it turns into durable consumption rather than free experimentation. The thesis breaks if next-quarter cRPO or organic growth slips back into low-teens or if AI bookings decelerate after the initial rollout cycle.

Key Decisions for Investors

• Buy CRM on any 2-4% post-earnings pullback; 1-3 month thesis is that cRPO/AI conversion supports a multiple re-rate, while the risk is the stock giving back gains once the market normalizes the non-operating EPS boost.
• Pair trade: long CRM / short IGV for 1-3 months to isolate relative outperformance from AI monetization versus a crowded software basket; target 8-12% spread capture if CRM holds guidance and IGV mean-reverts.
• If you want a more direct competitive hedge, long CRM / short HUBS over 3-6 months; CRM’s platform breadth and data integration should pressure mid-market software vendors that cannot match bundled AI economics.
• Set an alert on the next quarterly cRPO print and Agentforce monetization metrics; if cRPO growth falls below ~12% constant-currency or AI usage growth stalls, trim CRM exposure and cover relative longs.